SZSE:301126 (China)
Â
Class A
Â¥
8.93
(+0.56%)
Jun 21
New Key Statistics Module, Z-Score and F-Score
SZSE:301126 Key Ratios
Market Cap ¥ M | 1,844.10 |
Enterprise Value ¥ M | 4,544.17 |
P/E(ttm) | 47.00 |
PE Ratio without NRI | 32.12 |
Forward PE Ratio | -- |
Price/Book | 1.04 |
Price/Sales | 0.43 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 0.10 |
Revenue (TTM) ¥ M | 4,307.00 |
EPS (TTM) ¥ | 0.19 |
Beneish M-Score | -2.16 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -2.40 |
y-y EBITDA Growth Rate % | -6.70 |
EV-to-EBIT | 37.31 |
EV-to-EBITDA | 37.31 |
PEG | -- |
Shares Outstanding M | 206.51 |
Net Margin (%) | 0.89 |
Operating Margin % | 3.62 |
Pre-tax Margin (%) | 1.19 |
Quick Ratio | 1.02 |
Current Ratio | 1.31 |
ROA % (ttm) | 0.74 |
ROE % (ttm) | 2.20 |
ROIC % (ttm) | 3.35 |
Dividend Yield % | 0.45 |
Altman Z-Score | 1.36 |
SZSE:301126 Number of Guru Trades
SZSE:301126 Volume of Guru Trades
Gurus Latest Trades with SZSE:301126
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:301126 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Hunan Dajiaweikang Pharmaceutical Industry Co Ltd Insider Transactions
No Available Data